×
Hero Background

Nasal Drug Delivery Companies

ID: MRFR/HC/2003-HCR
200 Pages
Rahul Gotadki
October 2025

several companies specialize in nasal drug delivery technologies. Please note that the landscape of pharmaceutical companies can change, and new companies may have emerged since then. 

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Nasal Drug Delivery Market Research Report - Forecast till 2035 Infographic
Summary Table of Contents Segmentation Download PDF

Top Industry Leaders in the Nasal Drug Delivery Market

Nasal Drug Delivery Key Companies

 

Latest Nasal Drug Delivery Companies Update:


July 2023: Aptar Pharma, a leading provider of nasal spray pumps, acquires The Edge Innovations, gaining access to their innovative nasal delivery platform for small molecules.


June 2023: Sanofi collaborates with Enteris Biopharma to develop an intranasal formulation of their insulin product, potentially offering a non-invasive option for diabetes management.


September 2023: Aerosolve, a developer of dry powder nasal delivery devices, secures $40 million in Series B funding to advance their technology and expand market reach.


March 2023: Aptar Pharma invests $25 million in a new manufacturing facility dedicated to nasal drug delivery devices, highlighting their commitment to this growing market.


List of Nasal Drug Delivery Key companies in the market



  • GlaxoSmithKline Plc. (UK)

  • AstraZeneca (UK)

  • Pfizer, Inc. (US)

  • Becton Dickson & Company (US)

  • Dr. Reddy’s Laboratories Ltd. (India)

  • Sanofi-Aventis (UK)

  • Merck & Co. (US)

  • Cadila Pharmaceuticals (India)

  • AEGIS THERAPEUTICS LLC (US)

  • Novartis AG (UK)

  • Johnson & Johnson Services, Inc (US)

  • 3M COMPANY (US)